Business Context and Reporting Period
Company: Brooks Automation, Inc. (Note: Metadata referenced Azenta, Inc., but the filing text identifies Brooks Automation, Inc.)
Filing Type: Form 8-K (Current Report)
Reporting Date: July 27, 2011 (Event Date: July 25, 2011)
Event: Completion of Acquisition of Assets (Merger)
Key Financial Metrics and Transaction Details
The filing details the acquisition of Nexus Biosystems, Inc. ("Nexus"), a provider of automated sample management solutions. Key financial terms include:
- Aggregate Merger Consideration (Cash): $79,000,000
- Unrestricted Cash Acquired: $6,755,319.40
- Liabilities Assumed/Paid: $6,000,000 obligation to former owners of a business previously acquired by Nexus (paid by Brooks at closing).
Note: This filing does not provide standard operating metrics such as revenue, profit, cash flow, margins, or debt levels for Brooks Automation or Nexus. Unaudited pro forma financial statements are scheduled for filing by October 10, 2011.
Material Changes
On July 25, 2011, Brooks Automation consummated a merger with Nexus Biosystems, Inc. Nexus is now a wholly-owned subsidiary of Brooks. This transaction represents a material expansion of Brooks' asset base and entry into the automated sample management solutions market for pharmaceutical, biotech, and research institutions.
Outlook, Risks, and Contingencies
Management Commentary: The transaction was executed via a definitive Agreement and Plan of Merger. A press release was issued on the date of consummation.
Contingencies: The filing notes that unaudited pro forma condensed consolidated financial statements are required and will be filed by amendment on or prior to October 10, 2011.
Risks: The text does not explicitly list risk factors, though the assumption of the $6,000,000 liability and the integration of a new subsidiary are inherent transactional risks.
Investor Verification Checklist
- Verify the unaudited pro forma financial statements when filed by October 10, 2011, to assess the impact on earnings and liquidity.
- Confirm the net cash outflow calculation ($79M consideration + $6M liability - $6.75M cash acquired).
- Review the full Merger Agreement (Exhibit 2.1) for earn-out provisions or additional contingent liabilities not detailed in the summary.
- Monitor future 10-Q or 10-K filings for the first full period of consolidated results including Nexus.